TGA
Reminder: Urgent recall of Gentamicin Injection
There is potential for allergic reactions due to higher than expected amounts of histamine in the drugs, says TGA/Pfizer Consumers and health professionals are advised that Pfizer Australia, in consultation …
Calls for CWH to be fined $2 million
A public health advocate has lodged a complaint against Chemist Warehouse’s AFL Grand Final Promotion Associate Professor Ken Harvey from Monash University has lodged a complaint with the TGA, AHPRA …
Why upscheduling codeine won’t solve any problem
The rescheduling of OTC codeine-containing analgesics to prescription only won’t reduce misuse or increase patient safety, writes Professor Peter Carroll I believe the TGA’s decision to upschedule OTC codeine-containing preparations …
S3 esomeprazole to go S2
The Schedule 3 entry for proton-pump inhibitor esomeprazole is set to be deleted from 1 February 2018 The TGA delegate has made an interim decision to downschedule the PPI to Pharmacy …
New complementary meds tripled in past year
And adverse event reporting increased by more than 2,000 notifications, according to TGA’s latest stats Key observations for 2016-17 compared with 2015-16, provided by the TGA are as follows: 1. The …
What to do with your codeine stock after 1 February
The TGA has advised on codeine stock management following the upcoming reschedule to prescription only The TGA has updated information for wholesalers, sponsors and retail pharmacies regarding the upscheduling of …
Clash over S4 to S3 downscheduling
Doctors’s group disagrees with expansion of downscheduling S4 medicines with controls, citing patient safety concerns The Australian Medical Association (AMA) has again taken aim at pharmacy, this time over the …
New pathway for listed medicines drafted
The TGA has released its Therapeutic Goods Amendment (2017 Measures No. 1) Bill 2017 draft for consultation Submissions regarding the bill will be open until 9am on 5 September 2017. …
Bactroban shortage over
Production issues now resolved, manufacturer tells TGA Manufacturing issues that led to a shortage of the impetigo treatment Bactroban have been resolved, the TGA says. GSK, manufacturer of the treatment …
Heparin and Lignocaine recall, isolated incident likely
The TGA and Pfizer are working on a recall for Heparin and Lignocaine ampoules following a reported product mix-up The TGA said in a statement on Monday (14 August) that …
TGA’s 67 changes to permissible ingredients
For listed medicines, there are now four new ingredients, while eight have been removed due to safety issues The TGA has updated its permitted ingredients list for complementary medicines. This …
TGA guides pharmacists on codeine
After releasing a fact sheet about codeine changes for consumers in April, the regulatory body has now released one aimed at pharmacists Pharmacist fact sheet: Talking to your patients about …